asa glp 1 agonists Anesthetic Considerations for Patients Taking Glucagon-Like Peptide-1 GLP-1 medications safe to continue

Taken together, the Magruder et al

2Professor of Pharmaceutical Chemistry, Faculty of Pharmacy, SBB Dewan University, Karachi, Pakistan

Cardiovascular disease in the kidney transplant recipient: epidemiology, diagnosis and management strategies

doi: 10.3389/fragi.2025.1691007 Received 22 August 2025 Revised 30 October 2025 Accepted 06 November 2025 Published 27 November 2025 Volume 6 - 2025 Edited by Kieran Reid, Harvard Medical School, United States Reviewed by Shannon Hernon, Harvard Medical School, United States Nicole Bajdek, Harvard Medical School, United States Updates Copyright 2025 Dinkla, Beavers, Robbins, Akpalu, Wherry, Miller, Beavers, Espinoza, Trejo, Stepanenko and Cortes

sales surpassing $13 billion cementing its role as a cultural and clinical phenomenon